Anders Johansson

Publications
CV
Public outreach and news

Articles

Article: NEUROLOGY. 2022;99(10):e965-e976

Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease.

Bergquist F; Ehrnebo M; Nyholm D; Johansson A; Lundin F; Odin P; Svenningsson P; Hansson F; Bring L; Eriksson E; Dizdar N
Article: JOURNAL OF PERSONALIZED MEDICINE. 2021;11(8):720

Personalized Medicine Approach in Treating Parkinson's Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice.

Grétarsdóttir HM; Widman E; Johansson A; Nyholm D
Article: JOURNAL OF PERSONALIZED MEDICINE. 2021;11(6):519

Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist's Treatment Decisions?-An Observational Study in Routine Clinical Care of People with Parkinson's Disease.

Sundgren M; Andréasson M; Svenningsson P; Noori R-M; Johansson A
Article: JOURNAL OF NEUROLOGY. 2020;267(11):3411-3417

Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson's disease.

Hagell P; Höglund A; Hellqvist C; Johansson E-L; Löwed B; Sjöström A-C; Karlberg C; Lundgren M; Dizdar N; Johansson A; Willows T; Rådberg J; Bergquist F
Article: ARCHIVES OF REHABILITATION RESEARCH AND CLINICAL TRANSLATION. 2020;2(3):100064

A Pilot Study of the Feasibility and Effects of Table Tennis Training in Parkinson Disease.

Olsson K; Franzén E; Johansson A
Article: MOVEMENT DISORDERS. 2020;35(6):1046-1054

A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia.

Svenningsson P; Odin P; Dizdar N; Johansson A; Grigoriou S; Tsitsi P; Wictorin K; Bergquist F; Nyholm D; Rinne J; Hansson F; Sonesson C; Tedroff J; IRL752 Collaborators
Article: LAKARTIDNINGEN. 2020;117:FWED

[Parkinson's disease - heterogeneous and complex in its clinical presentation].

Bergquist F; Johansson A; Dizdar N; Widner H; Nyholm D; Odin P; Svenningsson P
Article: STEREOTACTIC AND FUNCTIONAL NEUROSURGERY. 2020;98(5):331-336

Pulse Width and Implantable Pulse Generator Longevity in Pallidal Deep Brain Stimulation for Dystonia: A Population-Based Comparative Effectiveness Study.

Ågren R; Bartek J; Johansson A; Blomstedt P; Fytagoridis A
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2019;26(10):1281-1288

Extensive validation study of the Parkinson's Disease Composite Scale.

Martinez-Martin P; Radicati FG; Rodriguez Blazquez C; Wetmore J; Kovacs N; Ray Chaudhuri K; Stocchi F; PDCS European Study Group
Article: PARKINSONISM & RELATED DISORDERS. 2019;64:112-117

Evaluation of a sensor algorithm for motor state rating in Parkinson's disease.

Johansson D; Thomas I; Ericsson A; Johansson A; Medvedev A; Memedi M; Nyholm D; Ohlsson F; Senek M; Spira J; Westin J; Bergquist F
Article: NPJ PARKINSONS DISEASE. 2019;5:26

Applications of the European Parkinson's Disease Association sponsored Parkinson's Disease Composite Scale (PDCS).

Balestrino R; Hurtado-Gonzalez CA; Stocchi F; Radicati FG; Chaudhuri KR; Rodriguez-Blazquez C; Martinez-Martin P; PDCS European Study Group
Article: CNS NEUROSCIENCE & THERAPEUTICS. 2018;24(5):439-447

Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry.

Johansson D; Ericsson A; Johansson A; Medvedev A; Nyholm D; Ohlsson F; Senek M; Spira J; Thomas I; Westin J; Bergquist F
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2018;25(3):503-511

The Parkinson's Disease Composite Scale: results of the first validation study.

Stocchi F; Radicati FG; Chaudhuri KR; Johansson A; Padmakumar C; Falup-Pecurariu C; Martinez-Martin P
Article: NPJ PARKINSONS DISEASE. 2018;4:35

Safety and tolerability of IRL790 in Parkinson's disease with levodopa-induced dyskinesia-a phase 1b trial.

Svenningsson P; Johansson A; Nyholm D; Tsitsi P; Hansson F; Sonesson C; Tedroff J
Article: PARKINSONS DISEASE. 2017;2017:4020198-7

Genetic Variations and mRNA Expression of NRF2 in Parkinson's Disease.

Ran C; Wirdefeldt K; Brodin L; Ramezani M; Westerlund M; Xiang F; Anvret A; Willows T; Sydow O; Johansson A; Galter D; Svenningsson P; Belin AC
Article: NEUROBIOLOGY OF AGING. 2016;45:212.e5-212.e11

Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden.

Ran C; Brodin L; Forsgren L; Westerlund M; Ramezani M; Gellhaar S; Xiang F; Fardell C; Nissbrandt H; Söderkvist P; Puschmann A; Ygland E; Olson L; Willows T; Johansson A; Sydow O; Wirdefeldt K; Galter D; Svenningsson P; Belin AC
Article: PARKINSONISM & RELATED DISORDERS. 2016;29:17-23

Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.

Pålhagen SE; Sydow O; Johansson A; Nyholm D; Holmberg B; Widner H; Dizdar N; Linder J; Hauge T; Jansson R; Bergmann L; Kjellander S; Marshall TS
Article: IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS. 2015;19(6):1829-1834

Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease.

Memedi M; Nyholm D; Johansson A; Pålhagen S; Willows T; Widner H; Linder J; Westin J
Article: SENSORS. 2015;15(9):23727-23744

Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's Disease.

Memedi M; Sadikov A; Groznik V; Žabkar J; Možina M; Bergquist F; Johansson A; Haubenberger D; Nyholm D
Article: AAPS JOURNAL. 2013;15(2):316-323

Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients.

Nyholm D; Odin P; Johansson A; Chatamra K; Locke C; Dutta S; Othman AA
Article: ACTA NEUROLOGICA SCANDINAVICA. 2012;126(6):e29-e33

Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease.

Pålhagen SE; Dizdar N; Hauge T; Holmberg B; Jansson R; Linder J; Nyholm D; Sydow O; Wainwright M; Widner H; Johansson A
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2012;19(8):1079-1085

Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson's disease.

Nyholm D; Klangemo K; Johansson A
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2012;19(6):820-826

Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial.

Nyholm D; Johansson A; Lennernäs H; Askmark H
Article: JOURNAL OF NEUROSCIENCE METHODS. 2010;190(1):143-148

A new computer method for assessing drawing impairment in Parkinson's disease.

Westin J; Ghiamati S; Memedi M; Nyholm D; Johansson A; Dougherty M; Groth T
Article: PARKINSONISM & RELATED DISORDERS. 2008;14(4):345-347

[(11)C]-PIB imaging in patients with Parkinson's disease: preliminary results.

Johansson A; Savitcheva I; Forsberg A; Engler H; Långström B; Nordberg A; Askmark H
Article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2007;255(1-2):17-22

Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET.

Johansson A; Engler H; Blomquist G; Scott B; Wall A; Aquilonius S-M; Långström B; Askmark H
Article: PROTEOMICS. 2004;4(12):4010-4018

Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry.

Ramström M; Ivonin I; Johansson A; Askmark H; Markides KE; Zubarev R; Håkansson P; Aquilonius S-M; Bergquist J
Article: NEUROREPORT. 2003;14(14):1867-1869

Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis.

Johansson A; Larsson A; Nygren I; Blennow K; Askmark H
Article: NEUROREPORT. 2002;13(17):2199-2201

VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis.

Nygren I; Larsson A; Johansson A; Askmark H
Article: ARCHIVES OF NEUROLOGY. 2001;58(2):232-237

Parkinsonism and neck extensor myopathy: a new syndrome or coincidental findings?

Askmark H; Eeg-Olofsson K; Johansson A; Nilsson P; Olsson Y; Aquilonius S
Article: NEUROREPORT. 2000;11(8):1781-1783

GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis.

Grundström E; Lindholm D; Johansson A; Blennow K; Askmark H
Show more

All other publications

Review: CLINICAL NEUROPHARMACOLOGY. 2015;38(5):170-176

A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1: 3 and 1: 1.7 in the Treatment of Cervical Dystonia: A Double-Blind, Randomized, Crossover Trial.

Rystedt A; Zetterberg L; Burman J; Nyholm D; Johansson A
Letter: PARKINSONISM & RELATED DISORDERS. 2013;19(7):701-702

The HLA-DRA variation rs3129882 is not associated with Parkinson's disease in Sweden.

Ran C; Willows T; Sydow O; Johansson A; Söderkvist P; Dizdar N; Ahmadi A; Olson L; Belin AC
Review: CLINICAL NEUROPHARMACOLOGY. 2012;35(1):6-14

Complexity of motor response to different doses of duodenal levodopa infusion in Parkinson disease.

Nyholm D; Johansson A; Aquilonius S-M; Hellquist E; Lennernäs H; Askmark H
Letter: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2011;82(12):1409-1412

Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.

Orth M; European Huntington's Disease Network; Handley OJ; Schwenke C; Dunnett S; Wild EJ; Tabrizi SJ; Landwehrmeyer GB
Review: CLINICAL NEUROPHARMACOLOGY. 2010;33(4):181-185

Circadian rhythmicity in levodopa pharmacokinetics in patients with Parkinson disease.

Nyholm D; Lennernäs H; Johansson A; Estrada M; Aquilonius S-M
Review: CLINICAL NEUROPHARMACOLOGY. 2008;31(2):63-73

Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure.

Nyholm D; Lewander T; Johansson A; Lewitt PA; Lundqvist C; Aquilonius S-M

Employments

Affiliated to Research, Department of Clinical Neuroscience, Karolinska Institutet, 2023-2026

Supervisor

Edvard Nilsson, Neuropsychiatric Effects of Deep Brain Stimulation and Levodopa-carbidopa Intestinal Gel in Advanced Parkinson’s Disease A comparative study, 2015

Articles

All other publications

Employments

Supervisor

News from KI

Events from KI